These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5731345)

  • 1. Warfarin metabolism during ethyl chlorophenoxyisobutyrate treatment.
    Pyörälä K; Ristola P; Myllylä G
    Ann Med Intern Fenn; 1968; 57(4):157-60. PubMed ID: 5731345
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
    Maroto ML; Priego JG; Piña M; Catalán RE
    Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 4. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)].
    Levy H
    Med Klin; 1974 Sep; 69(36):1441-7. PubMed ID: 4280008
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential hypolipidemic agents. XVI. Synthesis and plasma lipid-lowering properties of alpha-substituted ethyl 4-dibenzofuranyloxyacetates and ethyl 4-chlorophenoxyacetates. A comparative study.
    Högberg T; Bondesson G; Misiorny A; Stjernström NE
    Acta Pharm Suec; 1977; 14(2):137-48. PubMed ID: 906831
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug therapy for hyperlipidemia.
    Franklin FA; Margolis S
    Cardiovasc Clin; 1984; 14(3):265-84. PubMed ID: 6722855
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect on serum tocopherol levels of drug-induced decrease in serum lipids.
    Weiss P; Bianchine JR
    Am J Med Sci; 1969 Oct; 258(4):275-81. PubMed ID: 5823464
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT
    Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug therapy. VI. Therapy of hyperlipidemias.
    Holcenberg JS; Hazzard WR
    Northwest Med; 1970 Jul; 69(7):503-5. PubMed ID: 5469352
    [No Abstract]   [Full Text] [Related]  

  • 10. Aggressive medical therapy for the prevention and treatment of coronary artery disease.
    Malloy MJ; Kane JP
    Dis Mon; 1998 Jan; 44(1):1-40. PubMed ID: 9457050
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholesterol and coronary artery disease--issues in the 1990s.
    Chia BL
    Singapore Med J; 1991 Oct; 32(5):291-4. PubMed ID: 1788566
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of dyslipidemia.
    Akel MM; Salti I
    J Med Liban; 2001; 49(5):274-8. PubMed ID: 12243421
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antilipemics and atherosclerosis].
    Chiche P; Chekler P; Ribadeau-Dumas JL; Derrida R
    Coeur Med Interne; 1967 Apr; 6(2):235-43. PubMed ID: 5618970
    [No Abstract]   [Full Text] [Related]  

  • 14. [The clinical use of bis-(hydroxy-ethyl-thio)-1,10-decane in the treatment of hyperlipemic and dyslipemic conditions].
    Vailati G; Montini M; Simonutti M; Nosari I; Pagani G
    Clin Ter; 1978 May; 85(4):361-73. PubMed ID: 668273
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)].
    Ciobanu V; Zălaru MC; Ciocan A; Mihăilescu S
    Stud Cercet Med Interna; 1971; 12(1):67-80. PubMed ID: 5565781
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug treatment of hyperlipidemia.
    Berkowitz D
    Mod Treat; 1969 Nov; 6(6):1341-51. PubMed ID: 5377637
    [No Abstract]   [Full Text] [Related]  

  • 17. Adipokines and treatment with niacin.
    Westphal S; Borucki K; Taneva E; Makarova R; Luley C
    Metabolism; 2006 Oct; 55(10):1283-5. PubMed ID: 16979396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term administration of tyquanol in the treatment of patients with ischemic heart disease in combination with hyperlipidemia].
    Panchenko VM; Ershov AA; Isaev VA
    Klin Med (Mosk); 2003; 81(3):40-2. PubMed ID: 12698850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of halofenate on serum lipids.
    Aronow WS; Vangrow J; Pagano J; Khemka M; Vawter M; Papageorge's NP
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):897-903. PubMed ID: 4214664
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal management of cholesterol levels and the prevention of coronary heart disease in women.
    Mosca LJ
    Am Fam Physician; 2002 Jan; 65(2):217-26. PubMed ID: 11820486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.